Product Description
GLP3-RT – 10 | 20 | 30 | 40 mg
For In Vitro Research Use Only – Not for Human or Veterinary Application
Specifications:
- Quantity: 10 | 20 | 30 | 4 0 mg
- Form: Lyophilized Powder
GLP-3 RT is a novel triple-agonist research peptide that targets GIP, GLP-1, and glucagon receptors. It is being investigated in academic and laboratory research settings for its potential effects on metabolic regulation and related biological pathways.
Intended Use: This compound is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics.
Disclaimer:
This compound has not been evaluated by the FDA.
It is not intended to diagnose, treat, cure, or prevent any disease.
All use must comply with applicable institutional, local, and federal regulations.
Terms of Sale: By purchasing from REVYV Science, the buyer affirms they are a qualified researcher or institution.
All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
